Latest Auxilium Pharmaceuticals Inc. Stories
- Label expansion to broaden patient base who may benefit from nonsurgical collagenase therapy LYNBROOK, N.Y., Oct.
Estimated 35-40 Percent of Surgical Procedures to Treat DC Have Been Performed on Multiple Joints CHESTERBROOK, Pa., Oct.
NEW ORLEANS, Oct. 13, 2014 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
- Auxilium Shareholders to Receive $33.25 Per Share DUBLIN and CHESTERBROOK, Pa., Oct.
Board Unanimously Reaffirms Recommendation of QLT Transaction CHESTERBROOK, Pa., Sept. 22, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc.
Data Support CCH could be Used to Treat Two Affected Joints Concurrently; Positive Results Presented from Additional Studies Evaluating CCH Retreatment for Recurrent Contracture CHESTERBROOK,
MOUNTAIN VIEW, Calif. and CHESTERBROOK, Pa., Sept.
Adopts One Year Stockholder Rights Plan CHESTERBROOK, Pa., Sept. 17, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc.
- Expected to Reduce Annual Operating Expenses by At Least $75 Million - CHESTERBROOK, Pa., Sept.
- An imitative word; an onomatopoetic word.